Robert W. Baird Increases AdaptHealth (NASDAQ:AHCO) Price Target to $16.00

AdaptHealth (NASDAQ:AHCO) had its target price lifted by stock analysts at Robert W. Baird from $14.00 to $16.00 in a report released on Thursday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Robert W. Baird’s price target indicates a potential upside of 40.60% from the company’s current price.

Several other equities research analysts have also commented on AHCO. UBS Group cut their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, February 13th. Royal Bank of Canada boosted their price objective on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday. Truist Financial upped their price target on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Canaccord Genuity Group upped their price target on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Price Performance

NASDAQ:AHCO opened at $11.38 on Thursday. AdaptHealth has a 12 month low of $8.35 and a 12 month high of $11.90. The stock has a 50 day moving average of $9.92 and a two-hundred day moving average of $10.23. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. The firm has a market cap of $1.53 billion, a P/E ratio of -6.90, a price-to-earnings-growth ratio of 1.08 and a beta of 1.12.

Institutional Investors Weigh In On AdaptHealth

Large investors have recently made changes to their positions in the stock. Assetmark Inc. acquired a new position in AdaptHealth in the fourth quarter valued at approximately $28,000. Blue Trust Inc. lifted its holdings in AdaptHealth by 24.1% in the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after acquiring an additional 1,115 shares during the last quarter. Quarry LP lifted its holdings in AdaptHealth by 4,596.9% in the third quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after acquiring an additional 5,838 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its holdings in AdaptHealth by 15.4% in the fourth quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after acquiring an additional 1,690 shares during the last quarter. Finally, CIBC Asset Management Inc acquired a new position in AdaptHealth in the third quarter valued at approximately $122,000. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.